How I manage haematology patients with septic shock

British Journal of Haematology

Volumn 152, Issue 4, 2011, Pages 380-391

  Cohen, Jon ^a   Drage, Stephen ^b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Bone marrow transplantation; Haematological malignancy; Leukaemia; Sepsis; Septic shock

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CASPOFUNGIN; CEFTOBIPROLE; CEPHALOSPORIN; DALBAVANCIN; DAPTOMYCIN; DOBUTAMINE; DORIPENEM; DROTRECOGIN; ENDOTOXIN; FLUCONAZOLE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; ITRACONAZOLE; LINEZOLID; NORADRENALIN; OXYGEN; STEROID; TELAVANCIN; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ARTICLE; BACTEREMIA; BLOOD OXYGEN TENSION; CAPILLARY LEAK SYNDROME; CLINICAL ASSESSMENT; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; MYCOSIS; NEUTROPENIA; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESUSCITATION; SEPSIS; SEPTIC SHOCK; SICKLE CELL ANEMIA; SYSTEMIC DISEASE; THALASSEMIA; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; ANTI-INFECTIVE AGENTS; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC NEOPLASMS; HUMANS; RESUSCITATION; SHOCK, SEPTIC;

EID: 78851468957     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08550.x     Document Type: Article

References (88)

1. Adda, M.M.D., Coquet, I.M.D., Darmon, M.M.D., Thiery, G.M.D., Schlemmer, B.M.D. & Azoulay, E.M.D.P. (2008) Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Critical Care Medicine, 36, 2766-2772.
2. Annane, D., Sebille, V., Charpentier, C., Bollaert, P.-E., Francois, B., Korach, J.M., Capellier, G., Cohen, Y., Azoulay, E., Troche, G., Chaumet-Riffaut, P. & Bellissant, E. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. The Journal of the American Medical Association, 288, 862-871.
3. Annane, D., Bellissant, E., Bollaert, P.E., Briegel, J., Confalonieri, M., De, G.R., Keh, D., Kupfer, Y., Oppert, M. & Meduri, G.U. (2009) Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. The Journal of the American Medical Association, 301, 2362-2375.
4. Annane, D., Cariou, A., Maxime, V., Azoulay, E., D'honneur, G., Timsit, J.F., Cohen, Y., Wolf, M., Fartoukh, M., Adrie, C., Santre, C., Bollaert, P.E., Mathonet, A., Amathieu, R., Tabah, A., Clec'h, C., Mayaux, J., Lejeune, J. & Chevret, S. (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. The Journal of the American Medical Association, 303, 341-348.
5. Benenson, R.S., Kepner, A.M., Pyle, D.N. & Cavanaugh, S. (2007) Selective use of blood cultures in emergency department pneumonia patients. The Journal of Emergency Medicine, 33, 1-8.
6. Bernard, G.R., Vincent, J.-L., Laterre, P.F., LaRosa, S.P., Dhainaut, J.F., Lopez-Rodriguuez, A., Steingrub, J.S., Garber, G.E., Helterbrand, J., Ely, W. & Fisher, C.J. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine, 344, 699-709.
7. Bisharat, N., Omari, H., Lavi, I. & Raz, R. (2001) Risk of infection and death among post-splenectomy patients. Journal of Infection, 43, 182-186.
8. Böhme, A., Ruhnke, M., Buchheidt, D., Cornely, O.A., Einsele, H., Enzensberger, R., Hebart, H., Heinz, W., Junghanss, C., Karthaus, M., Krüger, W., Krug, U., Kubin, T., Penack, O., Reichert, D., Reuter, S., Silling, G., Südhoff, T., Ullmann, A.J. & Maschmeyer, G. (2009) Treatment of invasive fungal infections in cancer patients - Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematotology and Oncology (DGHO). Annals of Hematology, 88, 97-110.
9. Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M. & Sibbald, W.J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644-1655.
10. Bouza, E., Burillo, A. & Munoz, P. (2002) Cather related infections: diagnosis and intravascular treatment. Clinical Microbiology and Infection, 8, 265-274.
11. Brandtzaeg, P., Kerrulf, P., Gaustad, P., Skulberg, A., Bruun, J.N., Halvorsen, S. & Sorensen, E. (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. Journal of Infectious Diseases, 159, 195-204.
12. Brunkhorst, F.M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., Olthoff, D., Jaschinski, U., John, S., Rossaint, R., Welte, T., Schaefer, M., Kern, P., Kuhnt, E., Kiehntopf, M., Hartog, C., Natanson, C., Loeffler, M. & Reinhart, K. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine, 358, 125-139.
13. Castagnola, E. & Faraci, M. (2009) Management of bacteremia in patients undergoing hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy, 7, 607-621.
14. Cohen, J. (2009) Non-antibiotic strategies for sepsis. Clinical Microbiology and Infection, 15, 302-307.
15. Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suarez, F., Dhédin, N., Isnard, F., Ades, L., Kuhnowski, F., Foulet, F., Kuentz, M., Maison, P., Bretagne, S. & Schwarzinger, M. (2009) Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clinical Infectious Diseases, 48, 1042-1051.
16. Corona, A., Bertolini, G., Lipman, J., Wilson, A.P. & Singer, M. (2010) Antibiotic use and impact on outcome from bacteraemic critical illness: the Bacteraemia Study in Intensive Care (BASIC). Journal of Antimicrobial Chemotherapy, 65, 1276-1285.
17. Craig, W.A. & Ebert, S.C. (1992) Continuous infusion of beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy, 36, 2577-2583.
18. Dellinger, R.P., Levy, M.M., Carlet, J.M., Bion, J., Parker, M.M., Jaeschke, R., Reinhart, K., Angus, D.C., Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, J.F., Gerlach, H., Harvey, M., Marini, J.J., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, B.T., Townsend, S., Vender, J.S., Zimmerman, J.L. & Vincent, J.L. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Medicine, 34, 17-60.
19. Esteban, A., Frutos-Vivar, F., Ferguson, N.D., Arabi, Y., Apezteguia, C., Gonzalez, M., Epstein, S.K., Hill, N.S., Nava, S., Soares, M.-A., D'Empaire, G., Alia, I. & Anzueto, A. (2004) Noninvasive positive-pressure ventilation for respiratory failure after extubation. New England Journal of Medicine, 350, 2452-2460.
20. Fatkenheuer, G., Buchheidt, D., Cornely, O.A., Fuhr, H.-G., Karthaus, M., Kisro, J., Leithauser, M., Salwender, H., Sadhoff, T., Szelenyi, H. & Weissinger, F. (2003) Central venous catheter (CVC)-related infections in neutropenic patients. Annals of Hematology, 82, S149-S157.
21. Finfer, S., Chittock, D.R., Su, S.Y., Blair, D., Foster, D., Dhingra, V., Bellomo, R., Cook, D., Dodek, P., Henderson, W.R., Hebert, P.C., Heritier, S., Heyland, D.K., McArthur, C., McDonald, E., Mitchell, I., Myburgh, J.A., Norton, R., Potter, J., Robinson, B.G. & Ronco, J.J. (2009) Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine, 360, 1283-1297.
22. Gea-Banacloche, J.C., Opal, S.M., Jorgensen, J., Carcillo, J.A., Sepkowitz, K.A. & Cordonnier, C. (2004) Sepsis associated with immunosuppressive medications: an evidence-based review. Critical Care Medicine, 32, S578-S590.
23. Girmenia, C., Micozzi, M., Gentile, G., Santilli, S., Arleo, E., Cardarelli, L., Capria, S., Minotti, C., Cartoni, C., Brocchieri, S., Guerrisi, V., Meloni, G., Foà, R. & Martino, P. (2010) Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study. Journal of Clinical Oncology, 28, 667-674.
24. Hilbert, G., Grison, D., Vargas, F., Valentino, R., Gbikpi-Benissan, G., Dupon, M., Reiffers, J. & Cardinaud, J.P. (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. New England Journal of Medicine, 344, 481-487.
25. Holler, E., Kolb, H.J., Greinix, H., Perrotin, D., Campilho, F., Aversa, F., Gil, L., Cornelissen, J., Varanese, L., Schacht, A., Friese, A. & Rustige, J. (2009) Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD. Bone Marrow Transplantation, 43, 491-497.
26. Huang, J., Tang, Y.Q. & Sun, J.Y. (2010) Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections. Scandinavian Journal of Infectious Diseases, 42, 260-265.
27. Jones, A.E., Shapiro, N.I., Trzeciak, S., Arnold, R.C., Claremont, H.A., Kline, J.A. for the Emergency Medicine Shock Research Network (EMShockNet) Investigators. (2010) Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. The Journal of the American Medical Association, 303, 739-746.
28. Kroschinsky, F., Weise, M., Illmer, T., Haenel, M., Bornhaeuser, M., Hoeffken, G., Ehninger, G. & Schuler, U. (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Medicine, 28, 1294-1300.
29. Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., Gurka, D., Kumar, A. & Cheang, M. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine, 34, 1589-1596.
30. Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., Martinka, G., Keenan, S., Wood, G., Arabi, Y., Feinstein, D., Kumar, A., Dodek, P., Kravetsky, L., Doucette, S.; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. (2010) Early combination therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Critical Care Medicine, 38, 1773-1785.
31. LaRosa, S.P. & Opal, S.M. (2008) Sepsis strategies in development. Clinics in Chest Medicine, 29, 735-747.
32. Laupland, K.B., Kirkpatrick, A.W. & Delaney, A. (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Critical Care Medicine, 35, 2686-2692.
33. Lecuyer, L.M.D., Chevret, S.M.D.P., Thiery, G.M.D., Darmon, M.M.D., Schlemmer, B.M.D. & Azoulay, E.M.D.P. (2007) The ICU Trial: a new admission policy for cancer patients requiring mechanical ventilation. Critical Care Medicine, 35, 808-814.
34. Leroy, O., Gangneux, J.P., Montravers, P., Mira, J.P., Gouin, F., Sollet, J.P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B. & Lortholary, O. (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Critical Care Medicine, 37, 1612-1618.
35. Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.L. & Ramsay, G. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine, 31, 1250-1256.
36. Lin, M.Y., Weinstein, R.A. & Hota, B. (2008) Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrobial Agents and Chemotherapy, 52, 3188-3194.
37. Linden, P.K. (2009) Approach to the immunocompromised host with infection in the intensive care unit. Infectious Diseases Clinics of North America, 23, 535-556.
38. Malik, I., Hussain, M. & Yousuf, H. (2001) Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies. Journal of Infection, 42, 120-125.
39. Mancini, N., Carletti, S., Ghidoli, N., Cichero, P., Burioni, R. & Clementi, M. (2010) The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clinical Microbiology Reviews, 23, 235-251.
40. Marshall, J.C., Maier, R.V., Jimenez, M. & Dellinger, E.P. (2004) Source control in the management of severe sepsis and septic shock: an evidence-based review. Critical Care Medicine, 32, S513-S526.
41. Massion, P.B., Dive, A.M., Doyen, C., Bulpa, P., Jamart, J., Bosly, A. & Installe, E. (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Critical Care Medicine, 30, 2260-2270.
42. Mato, A.R., Luger, S.M., Heitjan, D.F., Mikkelsen, M.E., Olson, E., Ujjani, C., Jacobs, S., Miltades, A.N., Shah, P., Schuster, S.J., Carroll, M., Chauffe, A.D. & Fuchs, B.D. (2010) Elevation in serum lactate at the time of febrile neutropenia in hemodynamically stable patients with hematologic malignancies is associated with the development of septic shock within 48hours. Cancer Biology & Therapy, 9, 585-589.
43. McConnell, J.S. & Cohen, J. (1986) Release of endotoxin from E. coli by quinolones. Journal of Antimicrobial Chemotherapy, 18, 765-766.
44. McGrath, S., Chatterjee, F., Whiteley, C. & Ostermann, M. (2010) ICU and 6-month outcome of oncology patients in the intensive care unit. Quarterly Journal of Medicine, 103, 397-403.
45. Meisel, C., Schefold, J.C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., Reinke, P. & Volk, H.D. (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American Journal of Respiratory and Critical Care Medicine, 180, 640-648.
46. Mentec, H., Laetitia, M.-M., Rabbat, A., Varon, E., Le Turdu, F. & Bleichner, G. (2004) Blind and bronchoscopic sampling methods in suspected ventilator-associated pneumonia; a multicentre prospective study. Intensive Care Medicine, 30, 1319-1326.
47. Mermel, L.A., Allon, M., Bouza, E., Craven, D.E., Flynn, P., O'Grady, N.P., Raad, I.I., Rijnders, B.J., Sherertz, R.J. & Warren, D.K. (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 49, 1-45.
48. Micek, S.T., Welch, E.C., Khan, J., Pervez, M, Doherty, JA, Reichley, RM & Kollef, MH. (2010) Empiric combination therapy is associated with improved outcome against sepsis due to Gram negative bacteria: a retrospective analysis. Antimicrobial Agents & Chemotherapy, 54, 1742-1748.
49. Mohammad, R.A. (2010) Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shock. American Journal of Health-System Pharmacy, 67, 1238-1245.
50. Morrell, M.R., Micek, S.T. & Kollef, M.H. (2009) The management of severe sepsis and septic shock. Infectious Diseases Clinics of North America, 23, 485-501.
51. Nguyen, B., Rivers, E.P., Knoblich, B., Jacobsen, G., Muzzin, A., Ressler, J. & Tomlanovich, M. (2004) Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Critical Care Medicine, 32, 1637-1642.
52. Nobre, V., Harbarth, S., Graf, J., Rohner, P. & Pugin, J. (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. American Journal of Respiratory Critical Care Medicine, 177, 498-505.
53. Padkin, A., Goldfrad, C., Brady, A.R., Young, D., Black, N. & Rowan, K. (2003) Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Critical Care Medicine, 31, 2332-2338.
54. Pappas, P.G., Kauffman, C.A., Andes, D., Benjamin, Jr, D.K., Calandra, T.F., Edwards, Jr, J.E., Filler, S.G., Fisher, J.F., Kullberg, B.J., Ostrosky-Zeichner, L., Reboli, A.C., Rex, J.H., Walsh, T.J., Sobel, J.D.; Infectious Diseases Society of America. (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 48, 503-535.
55. Pasqualotto, A.C. & Severo, L.C. (2008) The importance of central venous catheter removal in patients with candidaemia: time to rethink our practice? Clinical Microbiology and Infection, 14, 2-4.
56. Paul, M., Soares-Weiser, K. & Leibovici, L. (2003) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. British Medical Journal, 326, 1111.
57. Peigne, V., Rusinová, K., Karlin, L., Darmon, M., Fermand, J.-P., Schlemmer, B. & Azoulay, É. (2008) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Medicine, 35, 512-518.
58. Penack, O., Beinert, T., Buchheidt, D., Einsele, H, Hebart, H, Kiehl, MG, Massenkeil, G, Schiel, X, Schleicher, J, Staber, PB, Wilhelm, S, Wolf, HH, Ostermann, H; German Society of Hematology and Oncology. (2006) Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology, 85, 424-433.
59. Pierrakos, C. & Vincent, J.-L. (2010) Sepsis biomarkers: a review. Critical Care, 14, R15.
60. Pildal, J. & Gøtzsche, P.C. (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clinical Infectious Diseases, 39, 38-46.
61. Provan, D., Nokes, T., Agrawal, S., Winer, J. & Wood, P. (2008) Clinical Guidlines for Immunoglobulin Use, 2nd edn. Department of Health, London.
62. Regazzoni, C.J., Irrazabal, C., Luna, C.M. & Poderoso, J.J. (2004) Cancer patients with septic shock: mortality predictors and neutropenia. Supportive Care in Cancer, 12, 833-839.
63. Richardson, S., Pallot, D., Hughes, T. & Littlewood, T. (2009) Improving management of neutropenic sepsis in the emergency department. British Journal of Haematology, 144, 617-618.
64. Rintala, E. (1994) Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scandinavian Journal of Infectious Diseases, 26, 77-84.
65. Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E. & Tomlanovich, M. (2001) Early goal directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine, 345, 1368-1377.
66. Roberts, J.A., Webb, S., Paterson, D., Ho, K.M. & Lipman, J. (2009) A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Critical Care Medicine, 37, 2071-2078.
67. Rubulotta, F., Marshall, J., Ramsay, G., Nelson, D., Levy, M. & Williams, M. (2009) Predisposition, insult/infection, response, and organ dysfunction: a new model for staging severe sepsis. Critical Care Medicine, 37, 1329-1335.
68. Sakr, Y., Sponholz, C., Tuche, F., Brunkhorst, F. & Reinhart, K. (2008) The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection, 36, 396-407.
69. Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., Regez, K., Schoenenberger, R., Henzen, C., Bregenzer, T., Hoess, C., Krause, M., Bucher, H.C., Zimmerli, W., Mueller, B. for the ProHOSP Study Group. (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. The Journal of the American Medical Association, 302, 1059-1066.
70. Simon, L., Gauvin, F., Amre, D.K., Saint-Louis, P. & Lacroix, J. (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical Infectious Diseases, 39, 206-217.
71. Sligl, W.I., Milner, Jr, D.A., Sundar, S., Mphatswe, W. & Majumdar, S.R. (2009) Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clinical Infectious Diseases, 49, 93-101.
72. Smith, T.J., Khatcheressian, J., Lyman, G.H., Ozer, H., Armitage, J.O., Balducci, L., Bennett, C.L., Cantor, S.B., Crawford, J., Cross, S.J., Demetri, G., Desch, C.E., Pizzo, P.A., Schiffer, C.A., Schwartzberg, L., Somerfield, M.R., Somlo, G., Wade, J.C., Wade, J.L., Winn, R.J., Wozniak, A.J. & Wolff, A.C. (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. Journal of Clinical Oncology, 24, 3187-3205.
73. Soubani, A.O.M.D. (2006) Critical care considerations of hematopoietic stem cell transplantation. Critical Care Medicine, 34, S251-S267.
74. Sprung, C.L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y.G., Benbenishty, J., Kalenka, A., Forst, H., Laterre, P.F., Reinhart, K., Cuthbertson, B.H., Payen, D. & Briegel, J. (2008) Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine, 358, 111-124.
75. Staudinger, T., Stoiser, B., Mullner, M., Locker, G.J., Laczika, K., Knapp, S., Burgmann, H., Wilfing, A., Kofler, J., Thalhammer, F. & Frass, M. (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Critical Care Medicine, 28, 1322-1328.
76. Stephens, D.P., Thomas, J.H., Higgins, A., Bailey, M., Anstey, N.M., Currie, B.J. & Cheng, A.C. (2008) Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock. Critical Care Medicine, 36, 448-454.
77. Tang, B., Eslick, G., Craig, J. & McLean, A. (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infectious Diseases, 7, 210-217.
78. The SAFE Study Investigators. (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine, 350, 2247-2256.
79. Toussaint, S. & Gerlach, H. (2009) Activated protein C for sepsis. New England Journal of Medicine, 361, 2646-2652.
80. Tunkel, A.R. & Sepkowitz, K.A. (2002) Infections caused by viridans streptococci in patients with neutropenia. Clinical Infectious Diseases, 34, 1524-1529.
81. Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., Van, W.E., Bobbaers, H. & Bouillon, R. (2006) Intensive insulin therapy in the medical ICU. New England Journal of Medicine, 354, 449-461.
82. Vardakas, K.Z., Samonis, G., Chrysanthopoulou, S.A., Bliziotis, I.A. & Falagas, M.E. (2005) Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials. Lancet Infectious Diseases, 5, 431-439.
83. Watkinson, P.J., Drage, S.M., Barber, V.S., Lowes, S. & Young, J.D. (2009) The incidence of severe sepsis: the influence of definitions. Intensive Care Medicine, 35, S11.
84. Williams, E.L., Hildebrand, K.L., McCormick, S.A. & Bedel, M.J. (1999) The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesthesia and Analgesia, 88, 999-1003.
85. Williams, M., Braun, L., Cooper, L., Johnston, J., Weiss, R., Qualy, R. & Linde-Zwirble, W. (2004) Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Critical Care, 8, R291-R298.
86. Wolf, H.H., Leithauser, M., Maschmeyer, G., Salwender, H., Klein, U., Chaberny, I., Weissinger, F., Buchheidt, D., Ruhnke, M., Egerer, G., Cornely, O., Fatkenheuer, G. & Mousset, S. (2008) Central venous catheter-related infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology, 87, 863-876.
87. Yang, K. & Guglielmo, B.J. (2007) Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Annals of Pharmacotherapy, 41, 1427-1435.
88. Zavascki, A.P., Goldani, L.Z., Li, J. & Nation, R.L. (2007) Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. Journal of Antimicrobial Chemotherapy, 60, 1206-1215.